FormBlends Reviews · FormBlends network
See how GLP-1 programs compare on eight public criteria before you sign up.
Twelve telehealth programs and pharmacies scored the same way from their own public pages, with the conflict disclosed: FormBlends runs this site and is scored too.
- 12
- programs and pharmacies evaluated from their own public pages
- Every score is built from the program's own public pages, nothing private.
- 24
- points on the rubric: eight rows, three points each. Not a rating.
- Eight questions, three points each. It is a checklist, not a star rating.
- 19 of 24
- FormBlends' own score after four re-evaluations on September 5, 2026, up from 9 and now the highest total on the site, scored on the same rubric with the conflict disclosed
- FormBlends' own score on the same rubric. We publish it because you should see it.
Start here
Three ways in, depending on what you need right now
- 01Provider comparison builderPick up to three evaluated programs and see the eight rubric rows side by side.
- 02Ro (Ro Body): evaluationRo scored 16 of 24. Its pages list brand drugs only, with a membership fee plus per-dose medication prices.
- 03Browse methodology4 pages, most recently updated September 5, 2026
Interactive
The calculator
Each runs in your browser, shows its formula, and prints a dated assumptions note. Nothing you type leaves the page.
Reading
Start with these
Each page opens with a plain-English summary, a figure drawn from the data, the numbers that matter, and what it means if you're considering treatment.
Evaluations
Ro (Ro Body): evaluation
You'll get: Ro scored 16 of 24. Its pages list brand drugs only, with a membership fee plus per-dose medication prices.
Ro's GLP-1 weight-loss membership scored on the FormBlends Reviews rubric from its public pages on 2026-09-04: brand-only medication list, membership and per-dose prices, questionnaire-first prescribing, named medical group and pharmacy, refund terms, privacy. 16 of 24.
Evaluations
Hims & Hers: evaluation
You'll get: Hims & Hers scored 15 of 24. Its pages now list brand drugs only, with a $149 monthly membership on top.
The Hims weight-loss membership scored on the FormBlends Reviews rubric from its public pages on 2026-09-04: brand product list and prices, membership fee, state-dependent visit model, named medical groups and pharmacies, thin refund terms, and the FDA and FTC documents on record. 15 of 24.
Evaluations
Calibrate: evaluation
You'll get: Calibrate scored 18 of 24 on our disclosure rubric, one of the highest totals on this site.
Calibrate's Metabolic Reset scored on the FormBlends Reviews rubric from public pages on 2026-09-04: brand-only insurance-billed medication, $199 a month with a 3-month commitment, video visits, named state practices, a 72-hour refund window and the most detailed support hours in the set. 18 of 24.
Evaluations
FormBlends: evaluation (the program that runs this site)
You'll get: FormBlends scored 19 of 24, the highest total on this site. FormBlends also runs this site and wrote this page.
FormBlends' own compounded GLP-1 program scored on the FormBlends Reviews rubric from its public pages, by the same team, with the conflict disclosed. Fourth read of 2026-09-05: named medical group and three named 503A pharmacies, one dated price list with a price-does-not-change-with-dose statement and no live page contradicting it, a lost-shipment rule, a plain-language privacy summary with Global Privacy Control honoured, against no live visit on request, no phone line, COAs on request only and no state of licensure for the medical group. 19 of 24, the highest total on the site. Was 9, then 15, then 18.
Guides
Red flags checklist for GLP-1 offers
You'll get: Four hard stops: no prescription required, research-use wording, generic Ozempic claims, and no named pharmacy for a compounded product.
Twenty things on a GLP-1 program's website or ad that should make you slow down, grouped by what they tell you, with the reason each one matters and what to do instead. Built from FDA statements and the patterns in our evaluations.
Live updates
What changed since this site was written
Sources checked October 23, 2026, refreshed every six hours.
Newest on PubMed
Papers indexed in the last year matching semaglutide or tirzepatide with telehealth or compounding (13 in total).
- Real-World Treatment Patterns and Weight Outcomes Before and After a Tirzepatide Price Increase in Over One Million Self-Paying UK Adults With Overweight or Obesity
Diabetes Obes Metab · October 14, 2026 · PubMed 42875827
- Peer Referral Pathways and 6-Month Outcomes in a Tirzepatide-Supported Digital Weight Loss Service: Retrospective Cohort Study
J Med Internet Res · September 28, 2026 · PubMed 42804756
- Compounded Semaglutide and Tirzepatide Products Use Unique Formulations but Efficacy and Safety Largely Unknown
Ann Pharmacother · September 1, 2026 · PubMed 41689811
- Original rDNA Semaglutide Versus Synthetic Copies: Differences and Clinical Implications
Cureus · August 21, 2026 · PubMed 42769283
- Inflammation-mediated facial nodules to compounded tirzepatide
JAAD Case Rep · June 17, 2026 · PubMed 42598502
FDA and enforcement tracker
FormBlends research feed, data as of September 4, 2026.
September 1, 2026 · Adverse-event report update
FDA GLP-1 concerns page updated: 990 adverse-event reports for compounded semaglutide and >730 for compounded tirzepatide (as of May 31, 2026); border screening and fake-pharmacy labelsAugust 28, 2026 · Label or price event
FDA approves Mounjaro (tirzepatide) to reduce MACE risk in adults with type 2 diabetes (SURPASS-CVOT)August 27, 2026 · Court decision
Fifth Circuit affirms summary judgment for FDA in both GLP-1 shortage cases (Nos. 25-10600 tirzepatide; 25-10758 semaglutide)August 24, 2026 · FDA warning letter
FDA warning letters to five peptide vendors: Peak Performance Peptides (735127), Royal Peptides (734884), NuScience Peptides (733652), Peptide Partners (735063), TXP Innovations dba Tex Peptides (735067)August 24, 2026 · FDA warning letter
FDA warning letter: TXP Innovations LLC dba Tex Peptides (Unapproved New Drugs/Misbranded)
Compounded price index
Median all-in cash price per 28 days across providers, as of September 3, 2026.
- semaglutide, month 1 at 0.25 mg/week
- $197
- median of 14 providers
- semaglutide, month 4 at 1 mg/week
- $199
- median of 13 providers
- tirzepatide, month 1 at 2.5 mg/week
- $268
- median of 14 providers
- tirzepatide, month 4 at 5 mg/week
- $299
- median of 12 providers
- September 3, 2026: Index, All, baseline 51 rows. First weekly snapshot. Changes against this baseline will be listed here with the date they were observed.
PubMed lists come from NCBI E-utilities and are not reviewed by us before they appear. Feeds are FormBlends Research data (CC BY 4.0); FormBlends sells compounded GLP-1 drugs and appears in the price index under the same rules as every other provider. Compounded drugs are not FDA approved.
Browse
Sections
22 pages across 3 sections, each sourced to a label, a trial or a dated manufacturer page.
Methodology
You'll get: 4 sourced pages, each with a plain-English opener
How every evaluation on this site is scored. Eight criteria from licensure to privacy, each scored 0 to 3...
Evaluations
You'll get: 12 sourced pages, each with a plain-English opener
Ro's GLP-1 weight-loss membership scored on the FormBlends Reviews rubric from its public pages on...
Guides
You'll get: 6 sourced pages, each with a plain-English opener
Twenty things on a GLP-1 program's website or ad that should make you slow down, grouped by what they tell...
How a score is earned
Each of the eight criteria has four written definitions, 0 to 3. We read the company's own program page, pricing page, terms, refund policy and privacy notice on a stated date and pick the definition that matches what is actually published. A score measures disclosure, not clinical quality: a program that publishes little scores low even if it treats people well. Every evaluation lists the pages it used with the access date, and says unknown where a fact was not findable.
The conflict, stated plainly
This site is run by the FormBlends editorial team. FormBlends sells compounded semaglutide and tirzepatide through its own program, which competes with several programs evaluated here. We scored FormBlends on the same rubric and published the result with its weak rows visible. Every evaluation page carries this disclosure. If you think a score is wrong, the correction route is on the About page and corrections are logged.